2-Oct-2026
Acadia Healthcare Provides Notice of Proposed Derivative Action Settlement
Business Wire (Fri, 25-Sep 4:05 PM ET)
Acadia Healthcare to Participate in 2026 Jefferies Healthcare Services and Technology Conference
Business Wire (Wed, 9-Sep 9:00 AM ET)
Did Acadia Healthcare Company, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
PRNewswire (Mon, 7-Sep 3:01 PM ET)
Business Wire (Fri, 4-Sep 5:54 PM ET)
PRNewswire (Fri, 31-Jul 10:00 AM ET)
Globe Newswire (Tue, 28-Jul 4:51 PM ET)
Business Wire (Tue, 28-Jul 4:05 PM ET)
Business Wire (Mon, 27-Jul 3:50 PM ET)
Market Chameleon (Wed, 25-Feb 6:14 AM ET)
Volume Growth Drives Acadia's Record Revenue in Q4 2025 as Leadership Shifts with New CEO
Market Chameleon (Wed, 25-Feb 2:54 AM ET)
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Its facilities and services are classified into the following categories: acute inpatient psychiatric facilities; specialty treatment facilities; CTCs; and residential treatment centers. In which Acute inpatient psychiatric facilities contribute the majority of revenue in the United States. The Company has one reportable segment, behavioral healthcare services. The behavioral healthcare services segment provides inpatient and outpatient behavioral healthcare services.
Acadia Healthcare Company trades on the NASDAQ stock market under the symbol ACHC.
As of October 2, 2026, ACHC stock price climbed to $28.06 with 1,320,331 million shares trading.
ACHC has a beta of 0.43, meaning it tends to be less sensitive to market movements. ACHC has a correlation of 0.00 to the broad based SPY ETF.
ACHC has a market cap of $2.61 billion. This is considered a Mid Cap stock.
Last quarter Acadia Healthcare Company reported $866 million in Revenue and $.38 earnings per share. This beat revenue expectation by $20 million and exceeded earnings estimates by $.02.
In the last 3 years, ACHC traded as high as $87.77 and as low as $11.43.
The top ETF exchange traded funds that ACHC belongs to (by Net Assets): IJR, VTI, IWM, AVUV, VB.
ACHC has underperformed the market in the last year with a price return of +5.4% while the SPY ETF gained +16.1%. ACHC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -12.1% and -1.0%, respectively, while the SPY returned +3.6% and +1.0%, respectively.
ACHC support price is $26.20 and resistance is $27.66 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACHC shares will trade within this expected range on the day.